• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

CAPC: Disease risks far outweigh adverse flea product concerns

May 13, 2009

CAPC cites low safety risks for topical spot-on flea and tick products following a recent EPA advisory.

Bel Air, Md.

-- The Companion Animal Parasite Council (CAPC) issued a statement citing low safety risks for topical spot-on flea and tick products. The action follows a recent advisory from the Environmental Protection Agency (EPA) cautioning consumers about an increase in adverse events (up to 40,000).

Mike Paul, DVM, executive director of CAPC, says in a written statement, "While these (adverse-reaction) figures are concerning, they must be interpreted in light of information that is absent from the report. An adverse event that is reported may be anything from disappointing results, unacceptable odors or temporary changes to the hair coat, to more significant events such as gastrointestinal upsets, respiratory signs like coughing or sneezing or skin irritations at the point of application. On rare occasions, serious and life-threatening symptoms and even death may occur."

Paul chides the report for not clarifying the nature or frequency of adverse events.

"The range of products used is amazingly broad," Paul adds. "Not only are these products specifically labeled for indication by species, they are also clearly labeled for frequency of application and dosage. There is no reference in the EPA report to adherence to these labeled restrictions."

The source of these products and handling directions is another area of concern, CAPC says.

Advertisement

Some are available over-the-counter, and some are illegally imported or not appropriately manufactured, Paul says. "Products dispensed by veterinarians with a client/patient relationship are the most completely supervised with regard to species application, dose and frequency of application, but even these products can be mishandled," he adds.

"It is important to consider this number in light of the total doses administered from veterinary sources, Internet sources and retail sources, a figure that is simply not available," Paul explains.

"We do have information on veterinary-dispensed products, and even in light of that number the percentage of adverse events is extremely low, and the percentage of major adverse events is miniscule. The incidence of adverse events should always be of concern, but must be interpreted in light of the above realities."

"The improved control of fleas and ticks has done much to improve the comfort level and quality of life of dogs and cats. Further, particularly in view of increased geographic ranges of external parasites and the diseases they carry, flea and tick control have significant implications in protecting human health. Ectoparasites and their control is a genuine zoonotic concern with very real public health implications."

As first reported in DVM Newsmagazine, flea and tick product makers were slated to meet with EPA officials in mid-May.

Related Content:

MedicalAssociationBreaking NewsParasitologyFeline Medicine
UC Davis oral surgeons repair kitten’s severe cleft palate
UC Davis oral surgeons repair kitten’s severe cleft palate
FDA approves generic drug for managing allergic dermatitis in cats
FDA approves generic drug for managing allergic dermatitis in cats
ABVS approves full recognition for shelter medicine practice
ABVS approves full recognition for shelter medicine practice

Advertisement

Latest News

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

Two pups find their forever homes while at Fetch Charlotte

View More Latest News
Advertisement